Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra J Mandrekar

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung CancerNathan R Foster, Lindsay A Renfro, Steven E Schild, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
JAMA Oncology|March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)Kenneth L Kehl, David Zahrieh, Ping Yang, et al.
Immunotherapy|April 21, 2021
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)Jacob M Sands, Sumithra J Mandrekar, David Kozono, et al.
Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Trials|August 9, 2022
Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experienceDavid Zahrieh, Shauna L Hillman, Angelina D Tan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagusAmitabh Chak, Navtej S Buttar, Nathan R Foster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemopreventionPaul J Limburg, Michelle R Mahoney, Katie L Allen Ziegler, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung CancerNathan R Foster, Lindsay A Renfro, Steven E Schild, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
JAMA Oncology|March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)Kenneth L Kehl, David Zahrieh, Ping Yang, et al.
Immunotherapy|April 21, 2021
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)Jacob M Sands, Sumithra J Mandrekar, David Kozono, et al.
Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Trials|August 9, 2022
Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experienceDavid Zahrieh, Shauna L Hillman, Angelina D Tan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagusAmitabh Chak, Navtej S Buttar, Nathan R Foster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemopreventionPaul J Limburg, Michelle R Mahoney, Katie L Allen Ziegler, et al.
Pageof 16